Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study

被引:3
|
作者
Hu, Ya [1 ,2 ]
Huang, Ziyuan [1 ,2 ]
Cao, Qianqian [1 ]
Chen, Bo [1 ,2 ]
Xu, Shungang [1 ,2 ]
Qiu, Wenxian [1 ,2 ]
You, Xiaohan [1 ,2 ]
Zhang, Ji [1 ,2 ]
Chen, Chaosheng [1 ,2 ,3 ]
机构
[1] Wenzhou Med Univ, Affifiliated Hosp 1, Dept Nephrol, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Inst Chron Kidney Dis, Wenzhou, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Dept Nephrol, Affifiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China
关键词
IgA nephropathy; nephrotic syndrome; proteinuria; OXFORD CLASSIFICATION;
D O I
10.1080/0886022X.2023.2267138
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Both primary IgA nephropathy (IgAN) with and without nephrotic syndrome (NS) can present massive proteinuria (24-h urinary protein >= 3.5 g/d). The clinical significance of massive proteinuria may be different in the two entities and needs further research.Methods: Data of 1870 patients with biopsy-proven IgAN in our hospital from January 2011 to December 2022 was retrospectively reviewed. A total of 242 IgAN patients with massive proteinuria were enrolled. Patients who presented with nephrotic syndrome at renal biopsy were included in the IgAN with NS cohort (IgAN-NS). The IgAN with nephrotic-range proteinuria cohort (IgAN-NR) consisted of 1:1 matched cases from the remaining according to age, gender, estimated glomerular filtration rate (eGFR) at baseline, and follow-up time. The clinical and pathological characteristics between the two cohorts were analyzed.Results: The IgAN-NS had a significantly higher proteinuria level than the IgAN-NR (p < .001). Cluster analysis revealed that proteinuria was associated with lipids in IgAN-NS, while it was associated with inflammatory indicators in IgAN-NR. When the complete remission of proteinuria (CR) was not achieved, the Kaplan-Meier analysis showed the prognosis of IgAN-NS was significantly worse than that of IgAN-NR (p = .04). Then, our GLMM model and line chart showed that the serum albumin level of the IgAN-NR was always evidently higher than that of the IgAN-NS while the significant difference in urinary albumin/creatinine ratio between the two cohorts gradually disappeared during the short-term follow-up (1 year). Moreover, the Cox regression analysis showed that the increased serum albumin was an independent protective factor for the poor outcomes (eGFR decreased from the baseline >= 30% continuously or reached end-stage renal disease [ESRD]).Conclusion: The IgAN-NS had poorer clinicopathologic manifestation than IgAN-NR, including severer massive proteinuria. When the CR was not achieved, the prognosis of IgAN-NS was inferior to that of the IgAN-NR.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study
    Li, Hongfen
    Wang, Fanghao
    Jia, Junya
    Yan, Tiekun
    Liu, Youxia
    Lin, Shan
    BMC NEPHROLOGY, 2022, 23 (01)
  • [2] The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study
    Hongfen Li
    Fanghao Wang
    Junya Jia
    Tiekun Yan
    Youxia Liu
    Shan Lin
    BMC Nephrology, 23
  • [3] Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
    Zhao, Jing-Li
    Wang, Jing-Jing
    Huang, Guo-Ping
    Feng, Chun-Yue
    MEDICINE, 2021, 100 (21) : E26050
  • [4] Corticosteroid in IgA nephropathy with moderate proteinuria: A retrospective cohort study
    Wang, Yu
    Yu, Jianwen
    Jiang, Yu
    Li, Jianbo
    Yimamuyushan, Aikeda
    Xia, Xi
    Fan, Li
    Huang, Fengxian
    Chen, Wei
    Liu, Qinghua
    NEPHROLOGY, 2024, 29 (05) : 268 - 277
  • [5] Distinct characteristics and prognosis of IgA nephropathy patients with nephrotic syndrome: a propensity score-matched cohort study
    Jiang, Yuanyuan
    Chen, Pei
    Zhao, Wenjing
    Liu, Lijun
    Shi, Sufang
    Lv, Jicheng
    Zhang, Hong
    FRONTIERS IN MEDICINE, 2024, 11
  • [6] Clinical Features and Outcomes of IgA Nephropathy with Nephrotic Syndrome
    Kim, Jwa-Kyung
    Kim, Jeong Ho
    Lee, Sang Choel
    Kang, Ea Wha
    Chang, Tae Ik
    Moon, Sung Jin
    Yoon, Soo Young
    Yoo, Tae-Hyun
    Kang, Shin-Wook
    Choi, Kyu Hun
    Han, Dae Suk
    Kie, Jeong Hae
    Lirn, Beom Jin
    Jeong, Hyeon Joo
    Han, Seung Hyeok
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (03): : 427 - 436
  • [7] Differences of clinicopathological characteristics and outcomes of IgA nephropathy patients with and without nephrotic syndrome
    Huang, Naya
    Li, Jianbo
    Ai, Zhen
    Guo, Lin
    Chen, Wei
    Liu, Qinghua
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (09) : 3003 - 3011
  • [8] Clinicopathological prognostic stratification for proteinuria and kidney survival in IgA nephropathy: a Japanese prospective cohort study
    Koike, Kentaro
    Kawamura, Tetsuya
    Hirano, Keita
    Nishikawa, Masako
    Shimizu, Akira
    Joh, Kensuke
    Katafuchi, Ritsuko
    Hashiguchi, Akinori
    Yano, Yuichiro
    Matsuzaki, Keiichi
    Matsushima, Masato
    Tsuboi, Nobuo
    Maruyama, Shoichi
    Narita, Ichiei
    Yokoo, Takashi
    Suzuki, Yusuke
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
  • [9] Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS)
    Tomonori Kimura
    Ryohei Yamamoto
    Mitsuaki Yoshino
    Ryuichi Sakate
    Enyu Imai
    Shoichi Maruyama
    Hitoshi Yokoyama
    Hitoshi Sugiyama
    Kosaku Nitta
    Tatsuo Tsukamoto
    Shunya Uchida
    Asami Takeda
    Toshinobu Sato
    Takashi Wada
    Hiroki Hayashi
    Yasuhiro Akai
    Megumu Fukunaga
    Kazuhiko Tsuruya
    Kosuke Masutani
    Tsuneo Konta
    Tatsuya Shoji
    Takeyuki Hiramatsu
    Shunsuke Goto
    Hirofumi Tamai
    Saori Nishio
    Kojiro Nagai
    Kunihiro Yamagata
    Hideo Yasuda
    Shizunori Ichida
    Tomohiko Naruse
    Tomoya Nishino
    Hiroshi Sobajima
    Toshiyuki Akahori
    Takafumi Ito
    Yoshio Terada
    Ritsuko Katafuchi
    Shouichi Fujimoto
    Hirokazu Okada
    Tetsushi Mimura
    Satoshi Suzuki
    Yosuke Saka
    Tadashi Sofue
    Kiyoki Kitagawa
    Yoshiro Fujita
    Makoto Mizutani
    Naoki Kashihara
    Hiroshi Sato
    Ichiei Narita
    Yoshitaka Isaka
    Clinical and Experimental Nephrology, 2022, 26 : 1170 - 1179
  • [10] Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS)
    Kimura, Tomonori
    Yamamoto, Ryohei
    Yoshino, Mitsuaki
    Sakate, Ryuichi
    Imai, Enyu
    Maruyama, Shoichi
    Yokoyama, Hitoshi
    Sugiyama, Hitoshi
    Nitta, Kosaku
    Tsukamoto, Tatsuo
    Uchida, Shunya
    Takeda, Asami
    Sato, Toshinobu
    Wada, Takashi
    Hayashi, Hiroki
    Akai, Yasuhiro
    Fukunaga, Megumu
    Tsuruya, Kazuhiko
    Masutani, Kosuke
    Konta, Tsuneo
    Shoji, Tatsuya
    Hiramatsu, Takeyuki
    Goto, Shunsuke
    Tamai, Hirofumi
    Nishio, Saori
    Nagai, Kojiro
    Yamagata, Kunihiro
    Yasuda, Hideo
    Ichida, Shizunori
    Naruse, Tomohiko
    Nishino, Tomoya
    Sobajima, Hiroshi
    Akahori, Toshiyuki
    Ito, Takafumi
    Terada, Yoshio
    Katafuchi, Ritsuko
    Fujimoto, Shouichi
    Okada, Hirokazu
    Mimura, Tetsushi
    Suzuki, Satoshi
    Saka, Yosuke
    Sofue, Tadashi
    Kitagawa, Kiyoki
    Fujita, Yoshiro
    Mizutani, Makoto
    Kashihara, Naoki
    Sato, Hiroshi
    Narita, Ichiei
    Isaka, Yoshitaka
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (12) : 1170 - 1179